Allogene Therapeutics Inc (ALLO) — Capital Reinvestment Ratio

Latest as of March 2018: 275.40x

Allogene Therapeutics Inc (ALLO) has a Capital Reinvestment Ratio of 275.40x as of March 2018, meaning it reinvests 275% of its operating cash flow ($5.00K) in capital expenditures ($1.38 Million). See ALLO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

275.40x
Capex / Operating Cash Flow

Operating Cash Flow

$5.00K
USD

Capital Expenditures

$1.38 Million
USD

Data as of

Mar 2018
Most recent filing

Annual Capital Reinvestment Ratio for Allogene Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Allogene Therapeutics Inc from None to None. For live market cap and broader valuation context, see Allogene Therapeutics Inc (ALLO) market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow